SCN2A

[SCN2A Asia Pacific @SCN2AAustralia]

Wishing the SCN2A community a healthy, happy and bright 2020.

In 2020, we will take further steps to improve the lives of those whose lives are affected by SCN2A. With clinical trials and potential new treatments on the horizon we are hopeful for a brighter future.

#SCN2A

[SCN2A Asia Pacific @SCN2AAustralia]

Want to hear the latest news on SCN2A? Sign up to our newsletter here https://t.co/iLvu6hsyWL

Updates on the Natural History Study, potential trials in 2020 (and beyond), the resources available for families & the medical profession and MORE.

#SCN2A #SCN2AInsights #cureSCN2A

[SCN2A @SCN2A]

https://t.co/3M2aTI2Vhn

[SCN2A Asia Pacific @SCN2AAustralia]

PODCAST: When Alex Nemiroff’s son Roger was born, he was determined to work towards finding treatments for #SCN2A. Alex is now the CEO of RogCon, which has a research program (RC-222) developing a ASO for GOF epilepsies. https://t.co/BcLZ7iUVln
https://t.co/4fp4aN5tds

#SCN2A

[Katherine Howell @drkbhowell]

Exciting times in the SCN2A world. Looking forward to this webinar 👇

[SCN2A @SCN2A]

Look out soon for some news on companies with advanced #SCN2A programs, including one planning to start human trials next year!

[GETA @geneticepilepsy]

GETA PRESENTATION 2019 - Prof. Steve Petrou.

The Importance of Disease Mechanism in Therapy: Lessons from SCN1A

#SCN1A #Dravet #GETA2019 #geneticepilepsy

https://t.co/GOwGLhYbIU

[Sara James @SaraJamesAus]

Here’s looking at you, #GETA2019! Thanks for joining us in Melbourne from around Australia and across the Pacific ⁦@GlobalGenes⁩ ⁦@Kcnq2Cure⁩ #genetics #Epilepsy

[SCN2A @SCN2A]

https://t.co/HyT0NjF2tS

[GETA @geneticepilepsy]

Interested in genetic epilepsy? Don’t miss our genetic epilepsy conference on May 4th 09:00 Melbourne time (UTC+10). Speakers include @ingridscheffer, @drkbhowell, Steven Petrou, Daniel Lowenstein, Emma Palmer and Annapurna Poduri. https://t.co/ImjkQkEDWH #geneticepilepsy

[SCN2A Asia Pacific @SCN2AAustralia]

The International SCN2A Natural History Study (NSH) is underway.
Registry versus NHS? https://t.co/U1hhEvvhRA
#naturalhistorystudy #NHS #SCN2A #cureSCN2A

[PerkinElmer Genomics @PKIGenomics]

Meaningful story by @Spectrum of the positive impact a genetic test can have on a person with autism. https://t.co/oWXqBNkooZ Our desire for patients to see these benefits drives our mission of offering affordable options for gene panels, #WES & #WGS

[FamilieSCN2A @FamilieSCN2A]

The #FamilieSCN2A Foundation is excited to announce the 2019 "Action Potential" grant will be accepting applications starting February 1, 2019. Letters of Intent are by due March 1, 2019.
Learn more @ https://t.co/9ZHyaZ1f41
#ActionPotential #CureSCN2A #SCN2A

[The Notorious EEG (M. Scott Perry MD) @TheNotoriousEEG]

This is such an important concept that has been demonstrated several times now. Treating #ADHD in children with #epilepsy does not increase risk of #seizures. If the child needs treatment of this common comorbity of epilepsy, it is ok to treat!

[SCN2A @SCN2A]

International Natural History Study on SCN2A Mutations!
https://t.co/SkVz9cI434

[SCN2A Asia Pacific @SCN2AAustralia]

Announcing the launch SCN2A Australia. We look forward to working with families, researchers, clinicians and professional bodies to improve the lives of those who have SCN2A and their families. Follow us to keep up with the latest on SCN2A. #SCN2A #geneticepilepsy #autism

[FamilieSCN2A @FamilieSCN2A]

For our very 1st #WarriorWednesday of 2019 we'd like to kick it off by honoring SCN2A Warriors Leah Schust and Carla Forbes (our Founder/President & Co-Founder/Vice President). There are not enough words of praise for these two SCN2A mamas! #SCN2A #CureSCN2A

[SCN2A @SCN2A]

RogCon Biosciences Launches with Late-Breaking Presentation on SCN2A Epilepsy at the 2018 AES Mee... https://t.co/4fk52FfRi6 via @YahooFinance

[SCN2A @SCN2A]

Interesting paper underscoring the ability to impact SCN2A patients at later stages.

[Channelopathy 2026 @Channelopath_26]

SCN2A in #Autism Spectrum Disorder by Kevin Bender. How does it work? See https://t.co/SC1VTvZzjf

[SCN2A @SCN2A]

Visual depiction of why #SCN2A differs from all the other monogenetic causes of #autism. https://t.co/O2WNQ4F28A

[Channelopathy 2026 @Channelopath_26]

SCN2A in #Autism Spectrum Disorder by Kevin Bender. How does it work? See https://t.co/SC1VTvZzjf